Inflammatory phenotype (sputum), serum and sputum periostin levels of individual patients included in the study. (DOCX 18Â kb
Scoring for severity of asthma modified by Eisnerâs method. Table S2: Pearson correlation coeffici...
Methods S1. Details of the safety protocol for the sub-optimisation of treatment, skin-prick testing...
Basophil activation marker dose response to IL-25. Isolated peripheral blood basophils from 8 allerg...
Sputum and blood cell counts of eosinophilic phenotypes classified by ICS treatment and healthy subj...
Background: Periostin levels are associated with airway eosinophilia and are suppressed by corticost...
Table S1. Post hoc analysis of SIRIUS (demographics and clinical characteristics). (DOC 45 kb
Additional file 2: Table S2. The statistical significance and confidence intervals for serum periost...
Table S1. Exacerbations within a 12-month follow-up in asthma patients grouped by YKL-40 levels. Tab...
Additional file 1: Table e1. Basic demographics of the PERF cohort. E-Figure1. A) Correlation betwee...
Additional file 1: Table S1. Correlation coefficients for the association of serum periostin and TNC...
Additional file 3: Table S3. Characteristics of patients divided into four groups according to serum...
Table S1. Protein analyte concentrations for benralizumab- and placebo-treated patients with asthma ...
Table S1. The Severity Scale of asthma patients in the Guidelines for Prevention and Treatment of Br...
Additional file 6: Table S6. Omalizumab-treated patients to divide into 4 groups according to serum ...
Pearson correlation coefficients matrix for inflammatory biomarkersâ expression in the lung submuc...
Scoring for severity of asthma modified by Eisnerâs method. Table S2: Pearson correlation coeffici...
Methods S1. Details of the safety protocol for the sub-optimisation of treatment, skin-prick testing...
Basophil activation marker dose response to IL-25. Isolated peripheral blood basophils from 8 allerg...
Sputum and blood cell counts of eosinophilic phenotypes classified by ICS treatment and healthy subj...
Background: Periostin levels are associated with airway eosinophilia and are suppressed by corticost...
Table S1. Post hoc analysis of SIRIUS (demographics and clinical characteristics). (DOC 45 kb
Additional file 2: Table S2. The statistical significance and confidence intervals for serum periost...
Table S1. Exacerbations within a 12-month follow-up in asthma patients grouped by YKL-40 levels. Tab...
Additional file 1: Table e1. Basic demographics of the PERF cohort. E-Figure1. A) Correlation betwee...
Additional file 1: Table S1. Correlation coefficients for the association of serum periostin and TNC...
Additional file 3: Table S3. Characteristics of patients divided into four groups according to serum...
Table S1. Protein analyte concentrations for benralizumab- and placebo-treated patients with asthma ...
Table S1. The Severity Scale of asthma patients in the Guidelines for Prevention and Treatment of Br...
Additional file 6: Table S6. Omalizumab-treated patients to divide into 4 groups according to serum ...
Pearson correlation coefficients matrix for inflammatory biomarkersâ expression in the lung submuc...
Scoring for severity of asthma modified by Eisnerâs method. Table S2: Pearson correlation coeffici...
Methods S1. Details of the safety protocol for the sub-optimisation of treatment, skin-prick testing...
Basophil activation marker dose response to IL-25. Isolated peripheral blood basophils from 8 allerg...